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INTRODUCTION
Intrastriatal grafting of autologous adrenal
medullary tissue has yielded modest benefits in
Parkinson’s disease (PD) patients /1/. Parallel
studies in non-human primates with experimen-
tal parkinsonism have shown that cografts of
autologous adrenal medulla and peripheral
nerve yield greater behavioral improvement and
graft survival/1/. Hence, over the past year we
have performed intrastriatal implantation of
autologous adrenal medulla/intercostal nerve
cografts in 3 patients with advanced PD and
report our early experience here.
METHODS
Three patients were selected and evaluated
using the Core Assessment Program for Intra-
cerebral Transplantation (CAPIT) protocol/2/.
They were required to have advanced idiopathic
PD (Hoehn & Yahr Stage 4 or 4) that was no
longer responding adequately to antiparkin-
sonian medications, be in good general health,
have 2 functioning adrenal glands, and give in-
formed consent. Patients were maintained on an
optimal medication regimen and 3 or more
baseline evaluations were performed over the 3-
6 months preceding surgery. The core of the
CAPIT evaluation consisted of "off’ (12 hours
after last medications) and "on" application of
the Unified Parkinson Disease Rating Scale
(UPDRS), timed motor performance tests (hand
pronation-supination test, hand/arm movement
between 2 points, finger dexterity, and stand-
walk-sit test), an L-dopa response test, and brain
MRI scanning pre-operatively and at 3 month
intervals post-operatively. We also performed
electrophysiologic movement time/reaction
studies requiring whole arm movements using a
computerized touchpad device/3/.
We chose 3 targets in the right striatum (2 in
the caudate and 1 in the putamen) for MR
and/or CT-guided stereotaxic implantation of
the cografts. A right adrenalectomy was per-
formed via a flank/retroperitoneal approach,
and a 3-5 cm piece of intercostal nerve was
harvested from a portion of the 11th rib
removed during adrenalectomy. Microdissection
removed adrenal cortex and epineurium, and
0.6-0.8mm diameter x 3-5 mm length portions of
medullary tissue were mixed with portions of
minced nerve and loaded into a stereotaxic
implantation cannula.
RESULTS
The three PD patients were males, aged 55,
45, and 53, and their duration of disease was 12,
8 and 16 years, respectively. Pre-operative
Hoehn & Yahr stages "off’ meds were 5, 4 and 4.
They all took carbidopa/L-dopa (137.5/850mg,
300/1200 mg, and 325/1300 mg daily, respec-
tively); 2 were on bromocriptine (#1 11.25 mg,
#3 3.75 mg daily); 1 was on selegiline (10
mg/d); 2 were on amantadine; and 1 was on
ethopropazine.
Surgery was uneventful and post-operative
CT/MR scans revealed accurate placement of
the grafts. There was no post-operative morbid-
ity and all 3 patients were discharged 5-7 days
post-op and maintained on their pre-op medica-
tion regimen.
Post-operative follow-up examinations were
performed at 3 month intervals (#1 3, 6, 9
mos.; #2- 3 and 6 mos.; #3 3 mos.). Clinically
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all 3 patients developed a mild increase of dys-
kinesias starting around 2-3 mos. post-op
without any change of medications (most
notable in patients 2 and 3). The post-op
UPDRS motor scores in the "off’ state changed
as follows: #1 3 mo. increased 23%, 6 mo.
decreased 14%, 9 mo. decreased 25%; #2 3
mo. decreased 25%, 6 mo. decreased 58%; #3
3 mo. increased 10%. Percent of waking day
spent in the "off’ condition changed as follows:
#1- 3 mo. increased 50%, 6 mo. decreased 0%,
9 mo. decreased 50%; #2 3 mo. decreased
54% and 6 mo. decreased 54%; #3 3 mo.
decreased 25%. Timed motor performance tests
at 6 mo. post-op in patients #1 and 2 "off’ meds
revealed the following % improvement: PRON-
SUP 18% #1, 44% #2; HAND-ARM 40% #1,
36% #2; FINGER DEXT 15% #1, 23% #2;
STAND-WALK-SIT 44% # 1, 21% #2.
Movement time (MT-bradykinesia) studies
"off’ meds revealed 10% improvement at 9 mo.
post-op for patient # 1 and 23% improvement at
6 mo. post-op for patient #2.
2. Flank adrenalectomy and stereotaxic implan-
tation significantly reduce post-operative
morbidity and recovery time.
2. Early results are encouraging, but longer
follow-up is needed. This procedure should
still be considered investigational.
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SUMMARY
1. Autologous intrastriatal adrenal medulla/
nerve cografting can be performed safely with
careful patient selection and a strong medical/
surgical team approach.